Cancer prevalence in primary mitochondrial disease patients and their families.
- DOI
- 10.1177/26330040261471914
- Published
- 2026 Jan-Dec
- Container
- Therapeutic advances in rare disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/26330040261471914,
title = {Cancer prevalence in primary mitochondrial disease patients and their families.},
author = {Dalwadi S and Engelhardt NM and Muraresku CC and Keith K and Valverde KD and Nathanson KL and Falk MJ},
year = {2026},
journal = {Therapeutic advances in rare disease},
doi = {10.1177/26330040261471914},
url = {https://doi.org/10.1177/26330040261471914}
}RIS
TY - JOUR TI - Cancer prevalence in primary mitochondrial disease patients and their families. AU - Dalwadi S AU - Engelhardt NM AU - Muraresku CC AU - Keith K AU - Valverde KD AU - Nathanson KL AU - Falk MJ PY - 2026 JO - Therapeutic advances in rare disease DO - 10.1177/26330040261471914 UR - https://doi.org/10.1177/26330040261471914 ER -
APA
S, D., NM, E., CC, M., K, K., KD, V., KL, N., & MJ, F. (2026). Cancer prevalence in primary mitochondrial disease patients and their families.. Therapeutic advances in rare disease. https://doi.org/10.1177/26330040261471914
Source records
- pubmed · retrieved 2026-09-26T07:52:46.844Z